Assessment of Pathological Prostate Cancer Characteristics in Men with Favorable Biopsy Features on Predominantly Sextant Biopsy

作者: Felix K.-H. Chun , Nazareno Suardi , Umberto Capitanio , Claudio Jeldres , Sascha Ahyai

DOI: 10.1016/J.EURURO.2008.04.099

关键词:

摘要: Abstract Background The rate of insignificant prostate cancer (IPCa) is increasing. Objectives To examine three end points in patients with a single, positive core and no high-grade (PCa) at biopsy, namely (1) clinical IPCa radical prostatectomy (RP), defined as organ-confined PCa Gleason score 6 or lower tumor volume Design, Setting, Participants Retrospective analysis 209 men one biopsy showing lower. Measurements : Detailed RP data were used multivariable logistic regression models. Their bias-corrected accuracy estimates quantified using the area under curve (AUC) method. Results Limitations At RP, was present 28 (13.4%) pathologically unfavorable PCa, 7 higher non-organ-confined reported 70 (33.5%) men; when 8 considered, proportion fell to 11%. Our models predicting different categories had an between 56% 68% for versus 65.1% 66.1% 61.7% nomograms Kattan et al Nakanishi al, respectively. are not applicable screening because they originate from referral population. Conclusions Despite highly favorable features, 11% 33% only minority confirmed IPCa. Neither clinically nor features could be predicted sufficient decision making.

参考文章(36)
Renske Postma, Fritz H. Schröder, Geert J.L.H. van Leenders, Robert F. Hoedemaeker, Andre N. Vis, Monique J. Roobol, Theodorus H. van der Kwast, Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening. European Urology. ,vol. 52, pp. 89- 97 ,(2007) , 10.1016/J.EURURO.2007.01.030
Shomik Sengupta, Michael L. Blute, Stephanie M. Bagniewski, Brant Inman, Bradley C. Leibovich, Jeffrey M. Slezak, Robert P. Myers, Horst Zincke, After radical retropubic prostatectomy ‘insignificant’ prostate cancer has a risk of progression similar to low-risk ‘significant’ cancer BJU International. ,vol. 101, pp. 170- 174 ,(2007) , 10.1111/J.1464-410X.2007.07270.X
Patrick J. Bastian, Leslie A. Mangold, Jonathan I. Epstein, Alan W. Partin, Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer. ,vol. 101, pp. 2001- 2005 ,(2004) , 10.1002/CNCR.20586
Shilajit D. Kundu, Kimberly A. Roehl, Xiaoying Yu, Jo Ann V. Antenor, Brian K. Suarez, William J. Catalona, Prostate Specific Antigen Density Correlates With Features of Prostate Cancer Aggressiveness The Journal of Urology. ,vol. 177, pp. 505- 509 ,(2007) , 10.1016/J.JURO.2006.09.039
H. Ballentine Carter, Anna Kettermann, Luigi Ferrucci, Patricia Landis, E. Jeffrey Metter, Prostate-Specific Antigen Velocity Risk Count Assessment: A New Concept for Detection of Life-Threatening Prostate Cancer During Window of Curability Urology. ,vol. 70, pp. 685- 690 ,(2007) , 10.1016/J.UROLOGY.2007.05.010
Michael W Kattan, James A Eastham, Thomas M Wheeler, Norio Maru, Peter T Scardino, Andreas Erbersdobler, Markus Graefen, Hartwig Huland, Hideshige Koh, Shahrokh F Shariat, Kevin M Slawin, Makoto Ohori, None, Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors The Journal of Urology. ,vol. 170, pp. 1792- 1797 ,(2003) , 10.1097/01.JU.0000091806.70171.41
M.H. Winkler, F.A. Khan, I.M. Hoh, A.A. Okeke, M. Sugiono, P. McInerney, G.B. Boustead, R. Persad, A.V. Kaisary, D.A. Gillatt, Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre audit. BJUI. ,vol. 93, pp. 725- 729 ,(2004) , 10.1111/J.1464-410X.2003.04715.X
FELIX K.-H. CHUN, ALBERTO BRIGANTI, SHAhROKH F. SHARIAT, MARKUS GRAEFEN, FRANCESCO MONTORSI, ANDREAS ERBERSDOBLER, THOMAS STEUBER, ANDREA SALONIA, EIKE CURRLIN, VINCENZO SCATTONI, MARTIN G. FRIEDRICH, THORSTEN SCHLOMM, ALEXANDER HAESE, UWE MICHL, RENZO COLOMBO, HANS HEINZER, LUC VALIQUETTE, PATRIZIO RIGATTI, CLAUS G. ROEHRBORN, HARTWIG HULAND, PIERRE I. KARAKIEWICZ, Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation BJUI. ,vol. 98, pp. 329- 334 ,(2006) , 10.1111/J.1464-410X.2006.06262.X
Gunnar Aus, Jan-Erik Damber, Ali Khatami, Hans Lilja, Johan Stranne, Jonas Hugosson, Individualized Screening Interval for Prostate Cancer Based on Prostate-Specific Antigen Level Archives of Internal Medicine. ,vol. 165, pp. 1857- 1861 ,(2005) , 10.1001/ARCHINTE.165.16.1857
Jochen Walz, Markus Graefen, Felix K.-H. Chun, Andreas Erbersdobler, Alexander Haese, Thomas Steuber, Thorsten Schlomm, Hartwig Huland, Pierre I. Karakiewicz, High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series European Urology. ,vol. 50, pp. 498- 505 ,(2006) , 10.1016/J.EURURO.2006.03.026